Last reviewed · How we verify

NaCl 9% isotonic — Competitive Intelligence Brief

NaCl 9% isotonic (NaCl 9% isotonic) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution. Area: Critical Care / Fluid and Electrolyte Management.

marketed Electrolyte replacement solution Critical Care / Fluid and Electrolyte Management Small molecule Live · refreshed every 30 min

Target snapshot

NaCl 9% isotonic (NaCl 9% isotonic) — Centre Hospitalier Universitaire de Nice. NaCl 9% isotonic solution restores and maintains electrolyte balance and fluid volume in the body.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NaCl 9% isotonic TARGET NaCl 9% isotonic Centre Hospitalier Universitaire de Nice marketed Electrolyte replacement solution
Plegisol In Plastic Container Calcium Chloride Pfizer marketed Electrolyte replacement solution Electrolyte balance and fluid homeostasis 1971-01-01
Normal Saline 0.9% Infusion Solution Bag Normal Saline 0.9% Infusion Solution Bag Vanderbilt University Medical Center marketed Crystalloid fluid / Electrolyte replacement solution
fisiologic serum fisiologic serum Hospital Universitari Vall d'Hebron Research Institute marketed Electrolyte replacement solution
% 0.9 Saline solution % 0.9 Saline solution Kecioren Education and Training Hospital marketed Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride, (24)NaCl 0,9% Sodium Chloride, (24)NaCl 0,9% University of Oulu marketed Electrolyte replacement solution
normal saline - injection normal saline - injection Montefiore Medical Center marketed Crystalloid fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

  1. Baxter Healthcare Corporation · 1 drug in this class
  2. Centre Hospitalier Universitaire Dijon · 1 drug in this class
  3. Centre Hospitalier Universitaire de Nice · 1 drug in this class
  4. Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
  5. Federico II University · 1 drug in this class
  6. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
  7. Nepal Health Research Council · 1 drug in this class
  8. Pfizer · 1 drug in this class
  9. Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
  10. TC Erciyes University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NaCl 9% isotonic — Competitive Intelligence Brief. https://druglandscape.com/ci/nacl-9-isotonic. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: